全部最新消息
-
FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphoma
FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell LymphomaFDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphomamore -
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple MyelomaFDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myelomamore
